The drug Trikafta has changed the lives of many Canadians living with cystic fibrosis. But in many other parts of the world, the drug is either not available — or if it is, it costs hundreds of thousands of dollars a year. That’s why Cheri Nel, who is based in Johannesburg, is suing American pharmaceutical company Vertex over its patent and price tag.
The scandal that rocked curling
This orangutan used medicinal plants to treat its wound
Canadians should be proud of Trans Mountain pipeline, says CEO Dawn Farrell
Documentary: What Can a Widow Be?
How do police decide to start a high-speed chase?
Israeli, Palestinian protests face off at McGill
Is Pierre Poilievre making a point or crossing a line?
The molecular approach to great-tasting food
Fifth Estate investigates controversial RCMP unit
Calgary zoning debate gets heated
Conservation efforts are working, study suggests
Fed-up consumers are boycotting Loblaws
Ben Johnson’s complicated legacy
Inside the pro-Palestinian encampment at UBC
Lucy Lawless on ‘warrior princess’ Margaret Moth
B.C. rolls back drug decriminalization
Saving the tiny western chorus frog
Tensions along the TMX pipeline expansion
Getting an IUD hurts. Does it have to?
Does a bee have an inner life?
Create your
podcast in
minutes
It is Free
Front Burner
Vinyl Cafe
Ideas
Someone Knows Something
Under the Influence with Terry O’Reilly